One-year outcome | PLADP | ||||||
---|---|---|---|---|---|---|---|
Normal responder* n = 506 | HOPR† n = 521 | LOPR‡ n = 682 | |||||
n(%) | n(%) | HR(95%CI) | P | n(%) | HR(95%CI) | P | |
Net adverse clinical events | 85 (16.8) | 103 (19.8) | 1.19 (0.89,1.61) | 0.247 | 175 (25.7) | 1.64 (1.25,2.14) | 0.000 |
Ischemic events | 11 (2.2) | 22 (4.2) | 1.99 (0.96,4.10) | 0.063 | 12 (1.8) | 0.83 (0.37,1.89) | 0.660 |
Death | 5 (1.0) | 12 (2.3) | 2.34 (0.82,6.66) | 0.111 | 3 (0.4) | 0.45 (0.11,1.88) | 0.273 |
MI | 5 (1.0) | 9 (1.7) | 1.78 (0.60,5.31) | 0.303 | 6 (0.9) | 0.93 (0.28,3.05) | 0.903 |
ST | 5 (1.0) | 11 (2.1) | 2.23 (0.77,6.43) | 0.138 | 5 (0.7) | 0.78 (0.23,2.70) | 0.693 |
TVR | 1 (0.2) | 6 (1.2) | 5.86 (0.70,48.86) | 0.102 | 4 (0.6) | 3.33 (0.37,29.89) | 0.282 |
Bleeding events | 80 (15.8) | 83 (16.1) | 0.99 (0.73,1.36) | 0.967 | 165 (24.2) | 1.61 (1.23,2.12) | 0.001 |
Major + Minor | 10 (2.0) | 5 (1.0) | 0.47 (0.16,1.39) | 0.172 | 17 (2.5) | 1.17 (0.53,2.60) | 0.701 |
Minimal | 70 (13.8) | 78 (15.1) | 1.09 (0.78,1.52) | 0.603 | 148 (21.7) | 1.59 (1.19,2.13) | 0.002 |